You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Original Contributions Incidence of Hospitalized Rhabdomyolysis in Patients Treated With Lipid-Lowering Drugs
David J. Graham; Judy A. Staffa; Deborah Shatin; Susan E. Andrade; Stephanie D. Schech; Lois La Grenade; Jerry H. Gurwitz; K. Arnold Chan; Michael J. Goodman; Richard Platt
JAMA 2004; 292: 2585-2590.
[Abstract][Full text][PDF]
Reviews Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis
Bruce M. Psaty; Curt D. Furberg; Wayne A. Ray; Noel S. Weiss
JAMA 2004; 292: 2622-2631.
[Abstract][Full text][PDF]
Commentaries Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: A Counterpoint
Controversies Bayer’s Response to "Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis"
Controversies Authors’ Reply to Bayer’s Response to "Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis"
Bruce M. Psaty; Curt D. Furberg; Wayne A. Ray; Noel S. Weiss
JAMA 2004; 292: 2658-2659.
[Extract][Full text][PDF]
Clinical Reviews Management of Fibromyalgia Syndrome
Don L. Goldenberg; Carol Burckhardt; Leslie Crofford
JAMA 2004; 292: 2388-2395.
[Abstract][Full text][PDF]
Original Contributions Differential Genetic Effects of ESR1 Gene Polymorphisms on Osteoporosis Outcomes
John P. A. Ioannidis; Stuart H. Ralston; Simon T. Bennett; Maria Luisa Brandi; Daniel Grinberg; Fotini B. Karassa; Bente Langdahl; Joyce B. J. van Meurs; Leif Mosekilde; Serena Scollen; Omar M. E. Albagha; Mariona Bustamante; Alisoun H. Carey; Alison M. Dunning; Anna Enjuanes; Johannes P. T. M. van Leeuwen; Carmelo Mavilia; Laura Masi; Fiona E. A. McGuigan; Xavier Nogues; Huibert A. P. Pols; David M. Reid; Stephanie C. E. Schuit; Rachael E. Sherlock; André G. Uitterlinden; for the GENOMOS Study
JAMA 2004; 292: 2105-2114.
[Abstract][Full text][PDF]
Original Contributions Use of -Blockers and Risk of Fractures
Raymond G. Schlienger; Marius E. Kraenzlin; Susan S. Jick; Christoph R. Meier
JAMA 2004; 292: 1326-1332.
[Abstract][Full text][PDF]
Original Contributions Effect of Galantamine Hydrobromide in Chronic Fatigue Syndrome: A Randomized Controlled Trial
C. V. Russell Blacker; David T. Greenwood; Keith A. Wesnes; Rosamund Wilson; Carol Woodward; Ian Howe; Tauhid Ali
JAMA 2004; 292: 1195-1204.
[Abstract][Full text][PDF]
-Blockers and Risk of Fractures